52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Ontada Signs Strategic Agreement With Merck To Facilitate Development Of Data-Driven Insights To Impact Quality Of Cancer Care
Mckesson Says In June, U.S. DOJ Served Civil Investigative Demand On Co Seeking Documents Related To Distribution Arrangements For Ophthalmology Products
McKesson Reports Fiscal 2022 First-Quarter Results
McKesson Corporation is focused distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.
Biotechnology & Drugs
6555 State Highway 161
Edward A. Mueller
Independent Chairman of the Board
Brian Scott Tyler
Chief Executive Officer, Director
Britt J. Vitalone
Chief Financial Officer, Executive Vice President
Chief Human Resource Officer, Executive Vice President
Executive Vice President, Chief Technology Officer, Chief Information Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
* DISTRIBUTORS ANNOUNCE PROPOSED OPIOID SETTLEMENT WILL PROCEED TO NEXT PHASE
A group of state attorneys general unveiled on Wednesday a landmark $26 billion settlement with large drug companies for allegedly fueling the deadly nationwide opioid epidemic, but the deal still requires support from thousands of local governments.
German drug distributor Phoenix Group has agreed to buy parts of U.S.-based McKesson's European operations, the two companies said on Wednesday, without providing financial details.
The three largest U.S. drug distributors are facing trial on Monday in West Virginia in a lawsuit accusing them of fueling the opioid crisis that has resulted in 500,000 overdose deaths in the United States over two decades.
The nation's "Big Three" leading drug distributors have failed to escape a lawsuit by the city of Huntington, West Virginia, and its county seeking to hold them liable for harms caused by the opioid epidemic.
Drug distributor McKesson Corp has lost a bid in a federal appeals court to wipe out its $6.9 million debt to bankrupt obesity drug maker Orexigen Therapeutics by offsetting it against $9.1 million Orexigen owed a McKesson subsidiary.
U.S. drug distributor McKesson Corp said on Monday it had begun distribution of Johnson & Johnson's COVID-19 vaccine.
Drug distributor McKesson Corp said on Monday it had begun distribution of Johnson & Johnson's COVID-19 vaccine. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)
McKesson Corp said on Tuesday it has distributed over 25 million doses of Moderna's COVID-19 vaccine in January and expects its contract with U.S. government to distribute vaccines to boost its full-year earnings.
* MCKESSON SAYS HAS DISTRIBUTED OVER 25 MILLION DOSES OF MODERNA'S COVID-19 VACCINE THROUGH JAN: CONF CALL
A Democratic U.S. lawmaker urged the Biden administration to involve additional major healthcare distributors in the shipment of COVID-19 vaccines to speed vaccinations, according to a letter seen by Reuters.
McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said on Wednesday.
McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said in a statement on Wednesday. (Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)
U.S. distribution of Moderna Inc's COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday, vastly widening the rollout started last week by Pfizer Inc.
U.S. distribution of a second COVID-19 vaccine, from Moderna, is ready to start shipping to more than 3,800 sites this weekend, vastly widening the rollout begun last week with Pfizer, the drug company and distributor McKesson said.
Drug distributors AmerisourceBergen Corp and Cardinal Health Inc on Thursday reported $7.62 billion in new charges between them related to talks to resolve thousands of lawsuits alleging they helped fuel the U.S. opioid epidemic.
McKesson Corp <MCK.N> on Tuesday said it and two other major U.S. drug distributors could be expected to pay up to $21 billion under a new proposal to resolve thousands of lawsuits alleging they helped fuel the U.S. opioid crisis.
Drug distributor McKesson Corp has won dismissal of a whistleblower lawsuit by two former employees accusing the company of doing an inadequate job of protecting its product, addictive opioids, from theft.
The U.S. Department of Health and Human Services (HHS) said on Friday that McKesson Corp <MCK.N> would be the central distributor for future coronavirus vaccines, sending the U.S. drug distributor's shares up more than 3%.
* HHS - TRUMP ADMINISTRATION COLLABORATES WITH MCKESSON FOR COVID-19 VACCINE DISTRIBUTION
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.